544220 Stock Overview
Provides diagnostic and healthcare tests and services in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Clinitech Laboratory Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹90.08 |
| 52 Week High | ₹120.75 |
| 52 Week Low | ₹84.00 |
| Beta | 0 |
| 11 Month Change | -21.48% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -25.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| 544220 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 6.2% | 1.5% | 1.0% |
| 1Y | n/a | 45.6% | 44.7% |
Return vs Industry: Insufficient data to determine how 544220 performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how 544220 performed against the Indian Market.
Price Volatility
| 544220 volatility | |
|---|---|
| 544220 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.4% |
Stable Share Price: 544220's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 544220's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 85 | Jagdish Nayak | clinitechlab.com |
Clinitech Laboratory Limited provides diagnostic and healthcare tests and services in India. It conducts various tests in the areas of biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology tests. The company was incorporated in 1990 and is headquartered in Navi Mumbai, India.
Clinitech Laboratory Limited Fundamentals Summary
| 544220 fundamental statistics | |
|---|---|
| Market cap | ₹205.60m |
| Earnings (TTM) | ₹3.71m |
| Revenue (TTM) | ₹64.03m |
55.4x
P/E Ratio3.2x
P/S RatioIs 544220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 544220 income statement (TTM) | |
|---|---|
| Revenue | ₹64.03m |
| Cost of Revenue | ₹13.78m |
| Gross Profit | ₹50.25m |
| Other Expenses | ₹46.53m |
| Earnings | ₹3.71m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.63 |
| Gross Margin | 78.47% |
| Net Profit Margin | 5.80% |
| Debt/Equity Ratio | 24.3% |
How did 544220 perform over the long term?
See historical performance and comparison